Clinical Trials Directory

Trials / Completed

CompletedNCT04396730

Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess how Cannabidiol (CBD) impacts the effectiveness of oral contraceptive (birth control) pills and if CBD changes the possible side effects of birth control pills when CBD and birth control pills are taken at the same time. This study explores the potential interaction between CBD and birth control pills by assessing serum levels of the contraceptive steroid hormones ethinyl estradiol and levonorgestrel in birth control pill users when they also use CBD.

Detailed description

Participants will be randomized to either the CBD or placebo for cycle one, followed by a washout cycle. For cycle three, participants will take the opposite of what they received in Cycle one. For example if they received CBD during cycle one they will take placebo for cycle 3.

Conditions

Interventions

TypeNameDescription
DRUGCannabidiol Oil400 mg Cannabidiol oil will be administered daily along with oral contraceptives daily for 24 days.
DRUGPlaceboPlacebo will be administered daily along with oral contraceptives daily for 24 days.
DRUGCombined oral contraceptive pillAll participants will receive oral contraceptives

Timeline

Start date
2020-04-08
Primary completion
2022-03-02
Completion
2022-03-02
First posted
2020-05-21
Last updated
2023-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04396730. Inclusion in this directory is not an endorsement.